Magnetic nanoparticle-based therapeutic agents for thermo-chemotherapy treatment of cancer.
暂无分享,去创建一个
[1] Janusz Skowronek,et al. Hyperthermia – description of a method and a review of clinical applications , 2007 .
[2] I. Puri,et al. The effects of magnetic nanoparticle properties on magnetic fluid hyperthermia , 2010 .
[3] J. Overgaard,et al. Hyperthermia: a potent enhancer of radiotherapy. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).
[4] K. Krishnan. Biomedical Nanomagnetics: A Spin Through Possibilities in Imaging, Diagnostics, and Therapy , 2010, IEEE Transactions on Magnetics.
[5] C. Grüttner,et al. Synthesis and functionalisation of magnetic nanoparticles for hyperthermia applications , 2013, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[6] P. Dhagat,et al. Multifunctional nanomedicine platform for concurrent delivery of chemotherapeutic drugs and mild hyperthermia to ovarian cancer cells. , 2013, International journal of pharmaceutics.
[7] Jinwoo Cheon,et al. Critical enhancements of MRI contrast and hyperthermic effects by dopant-controlled magnetic nanoparticles. , 2009, Angewandte Chemie.
[8] T. Ryan. Energy-based Treatment of Tissue and Assessment VI , 2009 .
[9] C. Heidelberger,et al. Selective heat sensitivity of cancer cells. Biochemical and clinical studies , 1967 .
[10] Manish K Jaiswal,et al. Dual pH and temperature stimuli-responsive magnetic nanohydrogels for thermo-chemotherapy. , 2014, Journal of Nanoscience and Nanotechnology.
[11] V. Cabuil,et al. Iron Oxide Monocrystalline Nanoflowers for Highly Efficient Magnetic Hyperthermia , 2012 .
[12] Xuesi Chen,et al. Novel water-soluble and pH-responsive anticancer drug nanocarriers: doxorubicin-PAMAM dendrimer conjugates attached to superparamagnetic iron oxide nanoparticles (IONPs). , 2011, Journal of colloid and interface science.
[13] Sébastien Lecommandoux,et al. Doxorubicin loaded magnetic polymersomes: theranostic nanocarriers for MR imaging and magneto-chemotherapy. , 2011, ACS Nano.
[14] M. Ward,et al. Thermoresponsive Polymers for Biomedical Applications , 2011 .
[15] P Wust,et al. Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique , 2005, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[16] A. Mediano,et al. Accurate measurement of the specific absorption rate using a suitable adiabatic magnetothermal setup , 2008 .
[17] P. Peer,et al. Correlation of structural and magnetic properties of Fe3O4 nanoparticles with their calorimetric and magnetorheological performance , 2013 .
[18] H. Maeda,et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[19] Brian P. Timko,et al. Remotely Triggerable Drug Delivery Systems , 2010, Advanced materials.
[20] X. An,et al. Microstructure study of liposomes decorated by hydrophobic magnetic nanoparticles. , 2012, Chemistry and physics of lipids.
[21] N. Scholler,et al. Facile immunotargeting of nanoparticles against tumor antigens using site-specific biotinylated antibody fragments. , 2013, Journal of biomedical nanotechnology.
[22] S. Sahoo,et al. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. , 2011, Advanced drug delivery reviews.
[23] C. Rinaldi,et al. Magnetic fluid hyperthermia: Advances, challenges, and opportunity , 2013, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[24] Florence Gazeau,et al. Magnetic targeting of magnetoliposomes to solid tumors with MR imaging monitoring in mice: feasibility. , 2006, Radiology.
[25] M. Mahmoudi,et al. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. , 2011, Advanced drug delivery reviews.
[26] A. Hart,et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial , 2000, The Lancet.
[27] M. Dewhirst,et al. Hyperthermia mediated liposomal drug delivery , 2006, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[28] R. T. Gordon,et al. Intracellular hyperthermia. A biophysical approach to cancer treatment via intracellular temperature and biophysical alterations. , 1979, Medical hypotheses.
[29] Jing Liu,et al. Stimuli-responsive magnetic nanomicelles as multifunctional heat and cargo delivery vehicles. , 2013, Langmuir : the ACS journal of surfaces and colloids.
[30] N. D. Thorat,et al. Surface functionalized LSMO nanoparticles with improved colloidal stability for hyperthermia applications , 2013 .
[31] L. Gerweck,et al. Response of cells to hyperthermia under acute and chronic hypoxic conditions. , 1979, Cancer research.
[32] H. Maeda. Macromolecular therapeutics in cancer treatment: the EPR effect and beyond. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[33] Sunil Kumar,et al. In vitro evaluation of PEGylated mesoporous MgFe2O4 magnetic nanoassemblies (MMNs) for chemo-thermal therapy. , 2013, Journal of materials chemistry. B.
[34] K. Hynynen,et al. Hyperthermia in cancer treatment. , 1990, Investigative radiology.
[35] Tej B. Shrestha,et al. Magnetic-Fe/Fe3O4-nanoparticle-bound SN38 as carboxylesterase-cleavable prodrug for the delivery to tumors within monocytes/macrophages , 2012, Beilstein journal of nanotechnology.
[36] Y. Jeong,et al. Image-guided prostate cancer therapy using aptamer-functionalized thermally cross-linked superparamagnetic iron oxide nanoparticles. , 2011, Small.
[37] Yuanyuan Cai,et al. Methotrexate-conjugated magnetic nanoparticles for thermochemotherapy and magnetic resonance imaging of tumor , 2012, Journal of Nanoparticle Research.
[38] Jonathan R. McDaniel,et al. Actively targeting solid tumours with thermoresponsive drug delivery systems that respond to mild hyperthermia , 2013, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[39] C. Alexander,et al. Stimuli responsive polymers for biomedical applications. , 2005, Chemical Society reviews.
[40] L. Meng,et al. Highly cross-linked and biocompatible polyphosphazene-coated superparamagnetic Fe3O4 nanoparticles for magnetic resonance imaging. , 2013, Langmuir : the ACS journal of surfaces and colloids.
[41] Rocío Costo,et al. Study of Heating Efficiency as a Function of Concentration, Size, and Applied Field in γ-Fe2O3 Nanoparticles , 2012 .
[42] P. Choyke,et al. Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target? , 2013, Theranostics.
[43] P. Guardia,et al. Tuning the Size, the Shape, and the Magnetic Properties of Iron Oxide Nanoparticles , 2011 .
[44] C. Winterford,et al. The role of apoptosis in the response of cells and tumours to mild hyperthermia. , 1991, International journal of radiation biology.
[45] Jun Fang,et al. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. , 2011, Advanced drug delivery reviews.
[46] S. Rybak,et al. A cytotoxic ribonuclease. Study of the mechanism of onconase cytotoxicity. , 1993, The Journal of biological chemistry.
[47] I. Andreu,et al. Accuracy of available methods for quantifying the heat power generation of nanoparticles for magnetic hyperthermia , 2013, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[48] P. Wust,et al. The cellular and molecular basis of hyperthermia. , 2002, Critical reviews in oncology/hematology.
[49] E. Gerner,et al. Heat shock proteins in thermotolerance and other cellular processes. , 1987, Cancer research.
[50] J. Lepock,et al. Cellular effects of hyperthermia: relevance to the minimum dose for thermal damage , 2003, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[51] David Needham,et al. Nanoscale Drug Delivery and Hyperthermia: The Materials Design and Preclinical and Clinical Testing of Low Temperature-Sensitive Liposomes Used in Combination with Mild Hyperthermia in the Treatment of Local Cancer. , 2011, The open nanomedicine journal.
[52] J. Hainfeld,et al. Intravenous magnetic nanoparticle cancer hyperthermia , 2013, International journal of nanomedicine.
[53] Matthias Zeisberger,et al. Size-dependant heating rates of iron oxide nanoparticles for magnetic fluid hyperthermia. , 2009, Journal of magnetism and magnetic materials.
[54] Hui Mao,et al. Metallic iron nanoparticles for MRI contrast enhancement and local hyperthermia. , 2008, Small.
[55] L. Trahms,et al. Investigation of Brownian and Néel relaxation in magnetic fluids , 1999 .
[56] Christian Bergemann,et al. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. , 2008, Biomaterials.
[57] Shyh-Dar Li,et al. Hyperthermia-induced drug targeting , 2013, Expert opinion on drug delivery.
[58] Jun Wang,et al. Redox-responsive nanoparticles from the single disulfide bond-bridged block copolymer as drug carriers for overcoming multidrug resistance in cancer cells. , 2011, Bioconjugate chemistry.
[59] Forrest M Kievit,et al. Chlorotoxin bound magnetic nanovector tailored for cancer cell targeting, imaging, and siRNA delivery. , 2010, Biomaterials.
[60] E. Hall,et al. Interaction of hyperthermia and chemotherapy agents; cell lethality and oncogenic potential. , 1994, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[61] Deping Wang,et al. Preparation and characterization of temperature-responsive magnetic composite particles for multi-modal cancer therapy , 2011, Journal of materials science. Materials in medicine.
[62] P. Liu,et al. Redox‐Responsive Molecular Nanoreservoirs for Controlled Intracellular Anticancer Drug Delivery Based on Magnetic Nanoparticles , 2012, Advanced materials.
[63] R. Issels. Hyperthermia adds to chemotherapy. , 2008, European journal of cancer.
[64] W. Tremel,et al. Highly water-soluble magnetic iron oxide (Fe3O4) nanoparticles for drug delivery: enhanced in vitro therapeutic efficacy of doxorubicin and MION conjugates. , 2013, Journal of materials chemistry. B.
[65] I. Robinson,et al. Size and shape control for water-soluble magnetic cobalt nanoparticles using polymer ligands , 2008 .
[66] J. Santamaría,et al. Magnetic nanoparticles for drug delivery , 2007 .
[67] D. Morton,et al. Normal tissue and solid tumor effects of hyperthermia in animal models and clinical trials. , 1979, Cancer research.
[68] Deping Wang,et al. Synthesis, characterization and in vitro cytotoxicity of self-regulating magnetic implant material for hyperthermia application , 2009 .
[69] E. Hall,et al. The oncogenic potential of a combination of hyperthermia and chemotherapy agents. , 1988, British Journal of Cancer.
[70] M. Kumar,et al. Cellular interaction of folic acid conjugated superparamagnetic iron oxide nanoparticles and its use as contrast agent for targeted magnetic imaging of tumor cells , 2012, International journal of nanomedicine.
[71] M. Barati,et al. New ${\rm T}_{\rm c}$-Tuned Manganese Ferrite-Based Magnetic Implant for Hyperthermia Therapy Application , 2013, IEEE Transactions on Magnetics.
[72] Yu Zhang,et al. Size dependence of specific power absorption of Fe3O4 particles in AC magnetic field , 2004 .
[73] Werner A. Kaiser,et al. Enhancement of AC-losses of magnetic nanoparticles for heating applications , 2004 .
[74] S. Dutz,et al. Magnetic particle hyperthermia—biophysical limitations of a visionary tumour therapy , 2007 .
[75] Yu Zhang,et al. Influence of morphology and surface exchange reaction on magnetic properties of monodisperse magnetite nanoparticles , 2012 .
[76] Yu Zhou,et al. A facile concentric-layered magnetic chitosan hydrogel with magnetic field remote stimulated drug release , 2013 .
[77] Kazuo Maruyama,et al. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.
[78] Y. Akao,et al. The synergistic effects of hyperthermia and anticancer drugs on induction of apoptosis , 2000, Medical Electron Microscopy.
[79] Cyrille Boyer,et al. Functional iron oxide magnetic nanoparticles with hyperthermia-induced drug release ability by using a combination of orthogonal click reactions. , 2013, Angewandte Chemie.
[80] P. Wust,et al. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme , 2010, Journal of Neuro-Oncology.
[81] Y. Yamini,et al. Magnetic nanoparticles: Synthesis, stabilization, functionalization, characterization, and applications , 2010 .
[82] Yitao Wang,et al. Polymeric micelles drug delivery system in oncology. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[83] Richard C. Willson,et al. Tuning the Magnetic Properties of Nanoparticles , 2013, International journal of molecular sciences.
[84] A. Mediano,et al. New insights into the heating mechanisms and self-regulating abilities of manganite perovskite nanoparticles suitable for magnetic fluid hyperthermia. , 2012, Nanoscale.
[85] Qiqing Zhang,et al. Controllable synthesis, magnetic and biocompatible properties of Fe3O4 and α-Fe2O3 nanocrystals , 2012 .
[86] P Jack Hoopes,et al. Magnetic nanoparticle hyperthermia enhancement of cisplatin chemotherapy cancer treatment , 2013, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[87] E. D. Hager,et al. Hyperthermia in Cancer Treatment: A Primer , 2006 .
[88] H. Maeda,et al. Exploiting the enhanced permeability and retention effect for tumor targeting. , 2006, Drug discovery today.
[89] Le Duc Tung,et al. Synthesis of nanoparticles for biomedical applications , 2010 .
[90] A. Saxena,et al. Effect of Onconase on double-stranded RNA in vitro. , 2009, Anticancer research.
[91] C. Song,et al. Blood flow in normal tissues and tumors during hyperthermia. , 1980, Journal of the National Cancer Institute.
[92] Albert Duschl,et al. Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle , 2013, Journal of Nanobiotechnology.
[93] J. Otte,et al. Hyperthermia in cancer therapy , 1988, European Journal of Pediatrics.
[94] Robert Ivkov,et al. Synthesis and antibody conjugation of magnetic nanoparticles with improved specific power absorption rates for alternating magnetic field cancer therapy , 2007 .
[95] Y. Qu,et al. The impact of hyperthermic chemotherapy on human gastric cancer cell lines: preliminary results. , 2006, Oncology reports.
[96] L. Trahms,et al. Time domain study of Brownian and Néel relaxation in ferrofluids , 1995 .
[97] A. Jordan,et al. Clinical applications of magnetic nanoparticles for hyperthermia , 2008, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[98] Z. Yin,et al. Magnetite nanoparticles as smart carriers to manipulate the cytotoxicity of anticancer drugs: magnetic control and pH-responsive release , 2012 .
[99] Takashi Nakagawa,et al. Suitability of commercial colloids for magnetic hyperthermia , 2009 .
[100] R. E. Rosensweig,et al. Heating magnetic fluid with alternating magnetic field , 2002 .
[101] Carlos Rinaldi,et al. EGFR-targeted magnetic nanoparticle heaters kill cancer cells without a perceptible temperature rise. , 2011, ACS nano.
[102] In vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled drug delivery. , 2010, Nanomedicine : nanotechnology, biology, and medicine.
[103] Peter Wust,et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. , 2010, The Lancet. Oncology.
[104] H. Maeda,et al. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.
[105] Domenico Osella,et al. The influence of temperature on antiproliferative effects, cellular uptake and DNA platination of the clinically employed Pt(II)-drugs. , 2008, Journal of inorganic biochemistry.
[106] D. Chaudhary,et al. Doxorubicin-conjugated mesoporous magnetic colloidal nanocrystal clusters stabilized by polysaccharide as a smart anticancer drug vehicle. , 2012, Small.
[107] H. Shokrollahi,et al. Ferrite-based magnetic nanofluids used in hyperthermia applications , 2012 .
[108] Xiaoying Ying,et al. Actively-targeted LTVSPWY peptide-modified magnetic nanoparticles for tumor imaging , 2012, International journal of nanomedicine.
[109] K. Delman,et al. The role of hyperthermia in optimizing tumor response to regional therapy , 2008, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[110] A. Carvalho,et al. Synthesis and characterization of magnetoliposomes for MRI contrast enhancement. , 2013, International journal of pharmaceutics.
[111] S. Salon,et al. On the measurement technique for specific absorption rate of nanoparticles in an alternating electromagnetic field , 2012 .
[112] Z. Siddik,et al. Cisplatin: mode of cytotoxic action and molecular basis of resistance , 2003, Oncogene.
[113] L. Tiefenauer,et al. Antibody-magnetite nanoparticles: in vitro characterization of a potential tumor-specific contrast agent for magnetic resonance imaging. , 1993, Bioconjugate chemistry.
[114] S. Curley,et al. Targeted hyperthermia using metal nanoparticles. , 2010, Advanced drug delivery reviews.
[115] R. Ningthoujam,et al. Magnetic chitosan nanocomposite for hyperthermia therapy application: Preparation, characterization and in vitro experiments , 2014 .
[116] Jean-Paul Fortin,et al. Intracellular heating of living cells through Néel relaxation of magnetic nanoparticles , 2008, European Biophysics Journal.
[117] P. Wust,et al. Magnetic Fluid Hyperthermia (MFH) , 1997 .
[118] M. El-Sayed,et al. Catalysis with transition metal nanoparticles in colloidal solution: nanoparticle shape dependence and stability. , 2005, The journal of physical chemistry. B.
[119] J F Gross,et al. Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature. , 1989, International journal of radiation oncology, biology, physics.
[120] Balachandran Jeyadevan,et al. Heat dissipation mechanism of magnetite nanoparticles in magnetic fluid hyperthermia , 2009 .
[121] Nguyen T. K. Thanh,et al. Magnetic Nanoparticles : From Fabrication to Clinical Applications , 2012 .
[122] J. Cheon,et al. Magnetically triggered dual functional nanoparticles for resistance-free apoptotic hyperthermia. , 2013, Angewandte Chemie.
[123] T. Ishiguchi,et al. Combination of chemotherapy and mild hyperthermia enhances the anti-tumor effects of cisplatin and adriamycin in human bladder cancer T24 cells in vitro , 2010 .
[124] D. Shieh,et al. In vivo anti-cancer efficacy of magnetite nanocrystal--based system using locoregional hyperthermia combined with 5-fluorouracil chemotherapy. , 2013, Biomaterials.
[125] Subhra Mohapatra,et al. Multifunctional Chitosan Magnetic-Graphene (CMG) Nanoparticles: a Theranostic Platform for Tumor-targeted Co-delivery of Drugs, Genes and MRI Contrast Agents. , 2013, Journal of materials chemistry. B.
[126] Eugene Shi Guang Choo,et al. Optimization of surface coating on Fe3O4 nanoparticles for high performance magnetic hyperthermia agents , 2012 .
[127] G. Balendiran,et al. The role of glutathione in cancer , 2004, Cell biochemistry and function.
[128] Zhichuan J. Xu,et al. Synthesis, Functionalization, and Biomedical Applications of Multifunctional Magnetic Nanoparticles , 2010, Advanced materials.
[129] W Hiddemann,et al. Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study. , 2001, European journal of cancer.
[130] J. Zee,et al. Heating the patient: a promising approach? , 2002 .
[131] Guido Kroemer,et al. Cell death by necrosis: towards a molecular definition. , 2007, Trends in biochemical sciences.
[132] P. Wust,et al. Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles , 1999 .
[133] S. Nie,et al. Therapeutic Nanoparticles for Drug Delivery in Cancer Types of Nanoparticles Used as Drug Delivery Systems , 2022 .
[134] S. Banerjee,et al. Magnetic Nanoparticles Grafted with Cyclodextrin for Hydrophobic Drug Delivery , 2007 .
[135] H. Maeda,et al. The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. , 2013, Advanced drug delivery reviews.
[136] M. Drofenik,et al. Synthesis and characterization of Mg1+xFe2−2xTixO4 nanoparticles with an adjustable Curie point , 2014 .
[137] J. Otlewski,et al. Tumor-specific hyperthermia with aptamer-tagged superparamagnetic nanoparticles , 2013, International journal of nanomedicine.
[138] P. Gutin,et al. Effects of hyperthermia on DNA interstrand crosslinking after treatment with BCNU in 9L rat brain tumor cells. , 1985, Radiation research.
[139] C. Winterford,et al. Apoptosis. Its significance in cancer and cancer Therapy , 1994, Cancer.
[140] R. Banerjee,et al. In vitro application of paclitaxel loaded magnetoliposomes for combined chemotherapy and hyperthermia. , 2012, Colloids and surfaces. B, Biointerfaces.
[141] Q. Pankhurst,et al. Nanoparticles functionalized with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells. , 2010, Biomaterials.
[142] M. Willingham. Cytochemical Methods for the Detection of Apoptosis , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[143] J. Pérez-Landazábal,et al. Effect of a SiO2 coating on the magnetic properties of Fe3O4 nanoparticles , 2012, Journal of physics. Condensed matter : an Institute of Physics journal.
[144] Tej B. Shrestha,et al. Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model , 2012, International journal of nanomedicine.
[145] Miqin Zhang,et al. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. , 2010, Advanced drug delivery reviews.
[146] Thomas H. Epps,et al. Stimuli responsive materials. , 2013, Chemical Society reviews.
[147] Nguyen T. K. Thanh,et al. Mechanisms of nucleation and growth of nanoparticles in solution. , 2014, Chemical reviews.
[148] Jintian Tang,et al. Magnetic-mediated hyperthermia for cancer treatment: Research progress and clinical trials , 2013 .
[149] B. Jeyadevan,et al. Heating efficiency of magnetite particles exposed to AC magnetic field , 2007 .
[150] D. Siemann,et al. The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents. , 2011, Cancer treatment reviews.
[151] N. Thanh,et al. Functionalisation of nanoparticles for biomedical applications , 2010 .
[152] K. Murase,et al. Impact of surface coating and particle size on the uptake of small and ultrasmall superparamagnetic iron oxide nanoparticles by macrophages , 2012, International journal of nanomedicine.
[153] Jia Zhang,et al. The anti-hepatoma effect of nanosized Mn–Zn ferrite magnetic fluid hyperthermia associated with radiation in vitro and in vivo , 2013, Nanotechnology.
[154] Q. Pankhurst,et al. Progress in applications of magnetic nanoparticles in biomedicine , 2009 .
[155] R. Ningthoujam,et al. Functionalization of La(0.7)Sr(0.3)MnO3 nanoparticles with polymer: studies on enhanced hyperthermia and biocompatibility properties for biomedical applications. , 2013, Colloids and surfaces. B, Biointerfaces.
[156] J. Bacri,et al. Magnetically induced hyperthermia: size-dependent heating power of γ-Fe2O3 nanoparticles , 2008, Journal of physics. Condensed matter : an Institute of Physics journal.
[157] V. Pillay,et al. Stimuli-responsive polymers and their applications in drug delivery , 2009, Biomedical materials.
[158] C. Kumar,et al. Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. , 2011, Advanced drug delivery reviews.
[159] Sarika Singh,et al. pH‐Responsive Peptide Mimic Shell Cross‐Linked Magnetic Nanocarriers for Combination Therapy , 2012 .
[160] R. Issels,et al. Hyperthermia in oncology. , 2001 .
[161] T. Porter,et al. Thermosensitive liposomes for localized delivery and triggered release of chemotherapy. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[162] Dexin Sun,et al. Dendrimer functionalized water soluble magnetic iron oxide conjugates as dual imaging probe for tumor targeting and drug delivery , 2013 .
[163] Cordelia Selomulya,et al. Particle size dependence of heating power in MgFe2O4 nanoparticles for hyperthermia therapy application , 2014 .
[164] T. Sau,et al. "Complex-shaped Metal Nanoparticles: Bottom-Up Syntheses and Applications" , 2012 .
[165] C. Ling,et al. Thermal enhancement of melphalan and oxaliplatin cytotoxicity in vitro , 2002, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[166] Y. Nishimura,et al. For the clinical application of thermochemotherapy given at mild temperatures. , 1999, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[167] Peter Wust,et al. Intracranial Thermotherapy using Magnetic Nanoparticles Combined with External Beam Radiotherapy: Results of a Feasibility Study on Patients with Glioblastoma Multiforme , 2006, Journal of Neuro-Oncology.
[168] M. Fujimura,et al. Antitumor effects of inductive hyperthermia using magnetic ferucarbotran nanoparticles on human lung cancer xenografts in nude mice , 2013, OncoTargets and therapy.
[169] A. Mohammed,et al. Trigger release liposome systems: local and remote controlled delivery? , 2012, Journal of microencapsulation.
[170] Hua Wei,et al. Design and development of polymeric micelles with cleavable links for intracellular drug delivery , 2013 .
[171] Y. Haik,et al. Ni1‐x Crx alloy for self controlled magnetic hyperthermia , 2009 .
[172] Yasuhiko Yoshida,et al. Curcumin and 5-Fluorouracil-loaded, folate- and transferrin-decorated polymeric magnetic nanoformulation: a synergistic cancer therapeutic approach, accelerated by magnetic hyperthermia , 2014, International journal of nanomedicine.
[173] K. Sugimachi,et al. Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: a prospective randomized trial. , 1994, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[174] Tina Hernandez-Boussard,et al. Doxorubicin pathways: pharmacodynamics and adverse effects , 2011, Pharmacogenetics and genomics.
[175] H. Gu,et al. Effects of hyperthermia with dextran magnetic fluid on the growth of grafted H22 tumor in mice , 2009, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[176] M. McHenry,et al. Evaluation of iron-cobalt/ferrite core-shell nanoparticles for cancer thermotherapy , 2008 .
[177] S. Ryu,et al. Aptamer-conjugated magnetic nanoparticles enable efficient targeted detection of integrin αvβ3 via magnetic resonance imaging. , 2014, Journal of biomedical materials research. Part A.
[178] Robert J. Griffin,et al. Improvement of Tumor Oxygenation by Mild Hyperthermia , 2001, Radiation research.
[179] P. Chandrasekharan,et al. Facile synthesis of water-stable magnetite nanoparticles for clinical MRI and magnetic hyperthermia applications. , 2010, Nanomedicine.
[180] P. Wust,et al. Hyperthermia in combined treatment of cancer. , 2002, The Lancet Oncology.
[181] W. Hennink,et al. Thermosensitive polymeric micelles for targeted drug delivery. , 2011, Nanomedicine.
[182] Yang Xu,et al. Radio-frequency induced in vitro thermal ablation of cancer cells by EGF functionalized carbon-coated magnetic nanoparticles , 2011 .
[183] Jie Ren,et al. Magnetocaloric effect in magnetothermally-responsive nanocarriers for hyperthermia-triggered drug release , 2012, Nanotechnology.
[184] Yulei Chang,et al. Synthesis and characterization of DOX-conjugated dendrimer-modified magnetic iron oxide conjugates for magnetic resonance imaging, targeting, and drug delivery , 2012 .
[185] P. Chow,et al. Thermoresponsive core–shell magnetic nanoparticles for combined modalities of cancer therapy , 2009, Nanotechnology.
[186] X. An,et al. Controllable release from magnetoliposomes by magnetic stimulation and thermal stimulation. , 2013, Colloids and surfaces. B, Biointerfaces.
[187] Hiroyuki Honda,et al. Complete regression of mouse mammary carcinoma with a size greater than 15 mm by frequent repeated hyperthermia using magnetite nanoparticles. , 2003, Journal of bioscience and bioengineering.
[188] Karen L Wooley,et al. Design of polymeric nanoparticles for biomedical delivery applications. , 2012, Chemical Society reviews.
[189] R C Miller,et al. Clinical hyperthermia: Results of a phase I trial employing hyperthermia alone or in combination with external beam or interstitial radiotherapy , 1982, Cancer.
[190] Brian C. Benicewicz,et al. Nanocomposites with Polymer Grafted Nanoparticles , 2013 .